We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
The documents are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Contact Officer by emailing foi@health.gov.au or calling the Department of Health on 1800 020 103 or 02 6289 1555.
| Date of release | FOI number | Documents |
|---|---|---|
| 15 June 2020 | FOI 1728 | Request for the number of SAS category B approval for DMX-200 [Propagermanium] from July 2017 up to 19 May 2020, including how many were provided 2020 YTD. |
| 15 June 2020 | FOI 1664 | Request for TGA clearance documents as submitted by Resonance Health Analysis Services Pty Ltd for FerriSmart artificial intelligence ARTG Entry: 296322. |
| 12 June 2020 | FOI 1704 | Documents relating to TGA application for ARTG Entry 325343 - Eyetelligence Pty Ltd |
| 9 June 2020 | FOI 1675 | Request for documents relating to '98 Alive Pty Ltd' products; details of exact composition (constituents and concentrations) of the melaleuca alternifolia oil active ingredient |
| 11 May 2020 | FOI 1474 | Request for TGA Review of chemical scheduling in relation to cosmetic and fragrance ingredients
|
| TBC | FOI 1588 | SAS Category B for medicinal cannabis products during the period 1/11/2016 to 12/03/2020 |
| 6 April 2020 | FOI 1408 | Request for documents relating to the Ethicon Endo Surgery intraluminal staples from 1/07/2012 to 30/07/2019 |
| 3 April 2020 | FOI 1486 | Request for documents regarding investigations into mass adverse events following administration of Gardasil at Sacred Heart College, Oakleigh, Victoria. |
| TBA | FOI 1530 | Request for documents relating to the registration and cancellation of the product Indocyanine Green or Cardiogreen |
| 30 March 2020 | FOI 1417 | Request for all minutes of pharmacovigilance (PV) committees and reports of PV investigations, which detail the investigation outcome, including associated PSUR assessment reports, related to the Gardasil vaccine, during 2006 and 2007. |
| 17 March 2020 | FOI 1546 | Request for the approved register entry and Product Information for Carboprost |
| 4 March 2020 | FOI 1429 | Request for the TGA evaluation of Lyrica (Pregabalin) ahead of its initial entry on the Australian Register of Therapeutic Goods in 2005 |
| 4 March 2020 | FOI 1539 | SAS Category B for medicinal cannabis during the period 19/11/2019 to 14/02/2020 |
| 4 March 2020 | FOI 1537 | Number of new patients commencing treatment of unregistered medicinal cannabis products for specified time periods in 2019 |
| 24 February 2020 | FOI 1482 | Request for Philip Morris International's application to amend Schedule 7 of the Poisons Standard - commercially prepared and packed tobacco for personal use in Australia. |
| 7 February 2020 | FOI 1173 | Documents relating to pre- and post-approval safety and performance issues of, and decision to discontinue supply of, the Essure device
|
| 5 February 2020 | FOI 1296 | Investigation into Lions Eye Bank NSW and infected corneal grafts |
| 29 January 2020 | FOI 1483 | Special Access Scheme Category A and B notifications/approvals for Ketoconazole tablets for the period July 2016-June 2019 |
| 9 January 2020 | FOI 1434 | SAS Category B for medicinal cannabis from August 2019 - latest month |
| 24 December 2019 | FOI 1425 | Request for the number of medical cannabis (MC) patients in Australia for the period August 2017 to October 2019 |
| 19 December 2019 | FOI 1409 | Special Access Scheme Category B pathway for medicinal cannabis from 1/9/2019 to 18/11/2019 |
| 16 December 2019 | FOI 1324 | Documents relating to pre-submission discussions relating to Sodium Oxybate or Xyrem |
| 11 December 2019 | FOI 1316 | Documents relating to Special Access Scheme approvals and Adverse Event reports for Pentosan Polysulfate Sodium |
| 9 December 2019 | FOI 1368 | Communication between TGA and ASADA relating to Thymosin Beta 4 |
| 21 November 2019 | FOI 1356 | Documents relating to Haemophilus Influenza B vaccine adverse event reports |
| 14 November 2019 | FOI 1327 | Document showing sender type of DAEN reports on vaccine injury or death |
| 13 November 2019 | FOI 1299 | PI and CMI documents for Oxycontin, Oxynorm capsules, Oxynorm liquids, Oxynorm tablets, Targin, Fentora, Actiq from 2000 to preceding the current online versions.
|
| 5 November 2019 | FOI 1366 | Documents relating to Hepatitis A vaccines adverse reaction reports in the Adverse Event Management System, not included in the public Database of Adverse Event Notifications |
| 5 November 2019 | FOI 1340 | Documents relating to Varivax & Varilrix adverse reaction reports in the Adverse Event Management System, not included in the public Database of Adverse Event Notifications |
| 1 November 2019 | FOI 1370 | Documents relating to Special Access Scheme/ Authorised Prescriber applications/notifications for vasopressin injection. |
| 30 October 2019 | FOI 1349 | Documents relating to Special One (1) document Access Scheme Category A released in full and B approvals/notifications. Category A: from 1/07/2018 to 16/07/2019 Category B: from 28/09/2018 to 27/09/2019 |
| 29 October 2019 | FOI 1360 | SAS Category A, B and C approvals for Fesoterodine for the period July 2017 to July 2019 |
| 29 October 2019 | FOI 1353 | Documents relating to adverse event reports for the Priorix and Pulserix vaccines contained in the Adverse Event Management System, not included in the Database of Adverse Event Notifications. |
| 29 October 2019 | FOI 1345 | Request for documents relating to Infanrix Hexa vaccine adverse reaction notifications contained within the Adverse Event Management System. |
| 15 October 2019 | FOI 1338 | SAS Category B applications for human dermis grafts in 2019 |
| 15 October 2019 | FOI 1311 | Request for documents relating to Special Access Scheme Category B pathway for medicinal cannabis products for the period 1/11/2016 to 31/08/2019 |
| 10 October 2019 | FOI 1310 | Special Access Scheme Category A notifications for carboprost and thiotepa in 2018 |
| 20 September 2019 | FOI 1265 | Documents relating to adverse reactions to the Fluzone high dose vaccine recorded in the Adverse Event Management System (AEMS) and not the Database of Adverse Event Notifications (DAEN) |
| 19 September 2019 | FOI 1258 | Documents relating to adverse reactions to rotavirus vaccines recorded in the Adverse Event Management System (AEMS) and not the Database of Adverse Event Notifications (DAEN) |
| 18 September 2019 | FOI 1262 | Documents relating to adverse reactions to Hepatitis B vaccines recorded in the Adverse Event Management System (AEMS) and not the Database of Adverse Event Notifications (DAEN) |
| 16 September 2019 | FOI 1261 | Document relating to adverse reactions to Priox Tetra & ProQuad vaccines recorded in the Adverse Event Management System (AEMS) and not the Database of Adverse Event Notifications (DAEN) |
| 13 September 2019 | FOI 1139 | Documents relating to the safety, efficacy and use of Risperdal |
| 12 September 2019 | FOI 1263 | Documents relating to adverse reactions to meningococcal vaccines recorded in the Adverse Event Management System (AEMS) and not the Database of Adverse Event Notifications (DAEN) |
| 6 September 2019 | FOI 1260 | Documents relating to adverse reactions to pneumococcal vaccines recorded in the Adverse Event Management System (AEMS) and not the Database of Adverse Event Notifications (DAEN) |
| 4 September 2019 | FOI 1258 | Documents relating to adverse reactions to the Zostavax vaccine recorded in the Adverse Event Management System (AEMS) and not the Database of Adverse Event Notifications (DAEN) |
| 28 August 2019 | FOI 1194 | Listing of clinical studies for Duloxetine (pre-CTD) |
| 12 August 2019 | FOI 1222 | Category B Special Access Scheme applications for medicinal cannabis products received from 16 March to 1 July 2019 |
| 18 July 2019 | FOI 1188 | Request for adverse event reports received by the TGA for all Human Papilloma Virus vaccines that reported an outcome of death, including abortion |
| 17 July 2019 | FOI 1117 | Request for correspondence about the application to import/use, and adverse event reports relating to the Birmingham Hip Replacement system. |
| 17 July 2019 | FOI 1132 | Request for a copy of the application to schedule Thymosin Beta 4 and Tb500 Section 22(1): Irrelevant information was redacted. |
| 10 July 2019 | FOI 1110 | Request for access to documents relating to Clinical Trial Exemption reviews conducted between July 2013 and July 2018 S47(1)(b): Document contains information that has commercial value that could reasonably be expected to be destroyed or diminished if it were disclosed was exempted and redacted. |
| 10 July 2019 | FOI 1103 | Request for correspondence between the TGA and Stephen Dank |
| 9 July 2019 | FOI 1177 | Request for documents regarding the Special Access Scheme Category B pathway for medicinal cannabis from 15/3/2019 to 31/5/2019. |
| 1 Jul 2018 to 30 Jun 2019 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2018 to Jun 2019 | |
| 1 Jul 2017 to 30 Jun 2018 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2017 to Jun 2018 | |
| 1 Jul 2016 to 30 Jun 2017 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2016 to Jun 2017 | |
| 1 Jul 2015 to 30 Jun 2016 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2015 to Jun 2016 | |
| 1 Jul 2014 to 30 Jun 2015 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2014 to Jun 2015 | |
| 1 Jul 2013 to 30 Jun 2014 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014 | |
| 1 Jul 2012 to 30 Jun 2013 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013 | |
| 1 Jul 2011 to 30 Jun 2012 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012 | |